JPWO2021200797A1 - - Google Patents

Info

Publication number
JPWO2021200797A1
JPWO2021200797A1 JP2022512194A JP2022512194A JPWO2021200797A1 JP WO2021200797 A1 JPWO2021200797 A1 JP WO2021200797A1 JP 2022512194 A JP2022512194 A JP 2022512194A JP 2022512194 A JP2022512194 A JP 2022512194A JP WO2021200797 A1 JPWO2021200797 A1 JP WO2021200797A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022512194A
Other languages
Japanese (ja)
Other versions
JP7628320B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021200797A1 publication Critical patent/JPWO2021200797A1/ja
Application granted granted Critical
Publication of JP7628320B2 publication Critical patent/JP7628320B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/7456—Factor V
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2470/00—Immunochemical assays or immunoassays characterised by the reaction format or reaction type
    • G01N2470/04—Sandwich assay format
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
JP2022512194A 2020-03-30 2021-03-29 変性ｈｄｌの定量方法、及びそれに用いる分析用試薬 Active JP7628320B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020059965 2020-03-30
JP2020059965 2020-03-30
PCT/JP2021/013229 WO2021200797A1 (ja) 2020-03-30 2021-03-29 変性ｈｄｌの定量方法、及びそれに用いる分析用試薬

Publications (2)

Publication Number Publication Date
JPWO2021200797A1 true JPWO2021200797A1 (https=) 2021-10-07
JP7628320B2 JP7628320B2 (ja) 2025-02-10

Family

ID=77929007

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022512194A Active JP7628320B2 (ja) 2020-03-30 2021-03-29 変性ｈｄｌの定量方法、及びそれに用いる分析用試薬

Country Status (5)

Country Link
US (1) US20230288437A1 (https=)
EP (1) EP4130030A4 (https=)
JP (1) JP7628320B2 (https=)
CN (1) CN115698713A (https=)
WO (1) WO2021200797A1 (https=)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0933525A (ja) * 1995-07-21 1997-02-07 Yamasa Shoyu Co Ltd 酸化ｈｄｌの測定法及びキット
WO2003006989A1 (fr) * 2001-07-12 2003-01-23 Kyowa Medex Co., Ltd. Procede de quantification de lipoproteines denaturees, reactifs pour la quantification de lipoproteines denaturees, procede de detection de maladies du systeme circulatoire et reactifs pour la detection de maladies du systeme circulatoire
US20100055796A1 (en) * 2007-04-11 2010-03-04 Markku Ahotupa Estimation and biological consequences of oxidative metabolism
JP4671823B2 (ja) * 2004-09-27 2011-04-20 シスメックス株式会社 血液凝固因子の不活化方法及び血液凝固因子不活化試料
WO2015098901A1 (ja) * 2013-12-27 2015-07-02 独立行政法人国立循環器病研究センター 抗血液凝固剤
WO2018079674A1 (ja) * 2016-10-31 2018-05-03 国立大学法人大阪大学 脂質異常症治療が必要な被検者の選別方法及び選別用試薬
WO2019159934A1 (ja) * 2018-02-14 2019-08-22 国立大学法人信州大学 融合タンパク質、及びそれを用いた高密度リポタンパク質の測定キット

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2200980C (en) 1994-11-30 2009-09-22 Tatsuya Sawamura Mammalian receptors for modified low-density lipoprotein
ATE512982T1 (de) * 2001-08-17 2011-07-15 Exothera L L C Verfahren und zusammensetzung zum gezielten einbringen in exosome
JP2003279571A (ja) * 2002-03-20 2003-10-02 Kyowa Hakko Kogyo Co Ltd 炎症性疾患検出方法、検出薬、およびその予防治療薬探索方法
JP5706669B2 (ja) 2010-11-10 2015-04-22 独立行政法人国立循環器病研究センター 融合タンパク質、核酸、ベクター、細胞、ｌａｂの測定方法、並びに、ｌａｂ測定用キット
JP6231307B2 (ja) 2013-06-27 2017-11-15 中野 恵正 機能不全ｈｄｌの測定方法、機能不全ｈｄｌ測定用キット、並びに、生活習慣病マーカーの測定方法
JP6096360B1 (ja) 2016-08-12 2017-03-15 旭サナック株式会社 ワーク姿勢変更装置および多工程圧造機
CN109580960A (zh) * 2019-01-14 2019-04-05 周明 细胞外囊泡的分离方法、以及检测细胞外囊泡表面标志物的方法和试剂盒

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0933525A (ja) * 1995-07-21 1997-02-07 Yamasa Shoyu Co Ltd 酸化ｈｄｌの測定法及びキット
WO2003006989A1 (fr) * 2001-07-12 2003-01-23 Kyowa Medex Co., Ltd. Procede de quantification de lipoproteines denaturees, reactifs pour la quantification de lipoproteines denaturees, procede de detection de maladies du systeme circulatoire et reactifs pour la detection de maladies du systeme circulatoire
JP4671823B2 (ja) * 2004-09-27 2011-04-20 シスメックス株式会社 血液凝固因子の不活化方法及び血液凝固因子不活化試料
US20100055796A1 (en) * 2007-04-11 2010-03-04 Markku Ahotupa Estimation and biological consequences of oxidative metabolism
WO2015098901A1 (ja) * 2013-12-27 2015-07-02 独立行政法人国立循環器病研究センター 抗血液凝固剤
WO2018079674A1 (ja) * 2016-10-31 2018-05-03 国立大学法人大阪大学 脂質異常症治療が必要な被検者の選別方法及び選別用試薬
WO2019159934A1 (ja) * 2018-02-14 2019-08-22 国立大学法人信州大学 融合タンパク質、及びそれを用いた高密度リポタンパク質の測定キット

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KAKINO, A. ET AL.: "A Novel Cell-free, Non-Fluorescent Method to Measure LOX-1-Binding Activity Corresponding to The Fun", JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, vol. 26, no. 11, JPN6021016073, 2019, pages 947 - 958, XP055853034, ISSN: 0005468906, DOI: 10.5551/jat.47183 *
KAKINO, A. ET AL.: "A NOVEL METHOD TO QUANTIFY THE BIOLOGICAL ACTIVITY OF MODIFIED HDL", INTERNATIONAL SYMPOSIUM ON ATHEROSCLEROSIS (ISA) 2018 ABSTRACT BOOK, vol. Vol.32, P1.008, JPN6021016071, 5 June 2018 (2018-06-05), pages 35, XP055635076, ISSN: 0005468907 *
垣野明美 ほか: "変性HDL活性測定系の樹立とリスク評価への有用性の検討", 日本生化学会大会プログラム・講演予稿集, vol. 第92回, 2P-386, JPN6021016070, 2019, pages 706 - 707, ISSN: 0005468908 *

Also Published As

Publication number Publication date
EP4130030A4 (en) 2024-03-27
EP4130030A1 (en) 2023-02-08
JP7628320B2 (ja) 2025-02-10
CN115698713A (zh) 2023-02-03
WO2021200797A1 (ja) 2021-10-07
US20230288437A1 (en) 2023-09-14

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)
BR102021016176A2 (https=)

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20230519

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20231212

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240910

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241105

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241126

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241206

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20241224

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250122

R150 Certificate of patent or registration of utility model

Ref document number: 7628320

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150